Economics conference considers tech, political impacts on global economy

Economists from around the world will come to campus Oct. 3-5 to explore the changing global economy. The conference is open to the public.

Around Cornell

Immune cells key in blood vessel damage, neurodegeneration

A new study from Weill Cornell Medicine researchers helps explain why having ApoE4 – the gene variant most closely linked to Alzheimer’s disease – increases the risk of neurodegeneration and white matter damage.

Volcanoes may help reveal interior heat on Jupiter moon

By examining Jupiter’s moon Io – the most volcanically active place in the solar system – Cornell astronomers can study a vital process in planetary formation and evolution: tidal heating.

Considering race in colon cancer prediction reduces disparities

Taking race into account when developing tools to predict a patient’s risk of colorectal cancer leads to more accurate predictions when compared with race-blind algorithms, researchers find.

Cornell, partners to make upstate NY a regional engine for better batteries

With funding from the National Science Foundation, Cornell and a group of institutional partners have created the Upstate New York Energy Storage Engine to advance energy storage technology and boost large-capacity battery manufacturing in the region.

From lab to patent: Undergrad creates smart syringe for bioprinting

A smart sensor that attaches to the tip of a syringe can measure, in real time, the concentration and viability of the cells that pass through it – a potential breakthrough for biomedical 3D printing and cell therapy.

Healthful milk protein puffs are an easy snack to swallow

Catering to an aging population, Cornell food scientists have created a nutritious snack made from milk for those who have trouble swallowing. These puffs dissolve in your mouth instantly. 

Reducing the cultural bias of AI with one sentence

“Cultural prompting” – asking an AI model to perform a task like someone from another part of the world – resulted in reduced bias in responses for the vast majority of the more than 100 countries tested by a Cornell-led research group.

Long-term metastatic melanoma survival dramatically improves on immunotherapy

About half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a  report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators.